Jump Financial, LLC Arbutus Biopharma Corp Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$2.23 - $3.1 $153,812 - $213,819	68,974 New	68,974 $208,000
Q2 2022 Aug 09, 2022	SELL	$1.98 - $3.17 $113,454 - $181,641	-57,300 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$2.42 - $3.98 $44,382 - $72,993	-18,340 Reduced 24.25%	57,300 $171,000
Q4 2021 Feb 10, 2022	BUY	$3.11 - $4.61 $235,240 - $348,700	75,640 New	75,640 $294,000

130

82.2M

4.82M

546K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $468M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.